Combivent UDV Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Adverse Reactions

Summary of the safety profile: Many of the listed undesirable effects can be assigned to the anticholinergic and beta2-sympathomimetic properties of ipratropium bromide + salbutamol (Combivent UDV). As with all inhalation therapy ipratropium bromide + salbutamol (Combivent UDV) may show symptoms of local irritation.
The most frequent side effects reported in clinical trials were headache, throat irritation, cough, dry mouth, gastro-intestinal motility disorders (including constipation, diarrhoea and vomiting), nausea, and dizziness.
Tabulated summary of adverse reactions: The following adverse reactions have been reported during used of ipratropium bromide + salbutamol (Combivent UDV) in clinical trials and during post-marketing experience. (See table.)

Click on icon to see table/diagram/image

View ADR Monitoring Form

Combivent UDV Adverse Reactions

ipratropium bromide + salbutamol

Manufacturer:

Boehringer Ingelheim

Distributor:

Metro Drug